ArticleOncology and therapy2021

Evaluation of the Effect of Proton Pump Inhibitors on the Efficacy of Dacomitinib and Gefitinib in Patients with Advanced Non-Small Cell Lung Cancer and EGFR-Activating Mutations.

Jerry Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.